Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)

<p><strong>Aim.</strong> The study was designed to assess the efficiency of exogenous nitric oxide supply to the extracorporeal circulation line for myocardial protection against ischemic-reperfusion injury in acute myocardial infarction simulation during cardiopulmonary bypass (CP...

Full description

Bibliographic Details
Main Authors: N. O. Kamenshchikov, I. A. Mandel, Yu. K. Podoksenov, S. L. Mikheev, S. S. Sementsov, L. N. Maslov, B. N. Kozlov, V. M. Shipulin
Format: Article
Language:Russian
Published: Meshalkin National Medical Research Center 2017-12-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:https://journalmeshalkin.ru/index.php/heartjournal/article/view/468
id doaj-2d4561a0dbe84eb38e5006041897ef75
record_format Article
collection DOAJ
language Russian
format Article
sources DOAJ
author N. O. Kamenshchikov
I. A. Mandel
Yu. K. Podoksenov
S. L. Mikheev
S. S. Sementsov
L. N. Maslov
B. N. Kozlov
V. M. Shipulin
spellingShingle N. O. Kamenshchikov
I. A. Mandel
Yu. K. Podoksenov
S. L. Mikheev
S. S. Sementsov
L. N. Maslov
B. N. Kozlov
V. M. Shipulin
Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
Патология кровообращения и кардиохирургия
защита миокарда
прекондиционирование
ишемически-реперфузионное повреждение
оксид азота
author_facet N. O. Kamenshchikov
I. A. Mandel
Yu. K. Podoksenov
S. L. Mikheev
S. S. Sementsov
L. N. Maslov
B. N. Kozlov
V. M. Shipulin
author_sort N. O. Kamenshchikov
title Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
title_short Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
title_full Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
title_fullStr Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
title_full_unstemmed Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
title_sort myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)
publisher Meshalkin National Medical Research Center
series Патология кровообращения и кардиохирургия
issn 1681-3472
2500-3119
publishDate 2017-12-01
description <p><strong>Aim.</strong> The study was designed to assess the efficiency of exogenous nitric oxide supply to the extracorporeal circulation line for myocardial protection against ischemic-reperfusion injury in acute myocardial infarction simulation during cardiopulmonary bypass (CPB) in the experiment. <br /><strong>Methods.</strong> Acute ischemia was simulated in rabbits (n = 20) with subsequent myocardial reperfusion. All animals were anesthetized and mechanically ventilated through a nasotracheal tube. The experiment included occlusion of the left coronary artery by its clamping with a ligature for 45 min with subsequent reperfusion for 120 min during CPB. All animals were divided into 2 equal groups: 10 rabbits received nitric oxide supply to the extracorporeal circulation line in a dose of 40 ppm throughout the entire CPB period (the main group); 10 rabbits made up the control group. The ratio of the infarction area to the risk area was determined, and the quantity and nature of ventricular arrhythmias were accessed. <br /><strong>Results.</strong> It was established that nitric oxide supply through the extracorporeal circulation line during CPB had a pronounced infarct-limiting effect, the infarct area to the risk area ratio decreased by 15% as compared to the control group, р = 0.0002. There was also a significant antiarrhythmic effect. A lesser quantity of polytopic and polymorphic ventricular extrasystoles were observed in the main group during periods of ischemia and reperfusion (p = 0.003 and p = 0.012). A statistically significant decrease in the venoarterial gradient of the partial pressure of carbon dioxide in the main group was associated with an increase in the urine flow rate amounting to 1.4 [1.3; 1.5] ml/kg/h in the main group and 1.15 [1; 1.3] ml/kg/h in the control group, p = 0.013. <br /><strong>Conclusion.</strong> The data obtained during the experiment demonstrate the presence of cardioprotective properties of nitric oxide delivered to the extracorporeal circulation line when simulating myocardial ischemic-reperfusion injury. These properties manifest themselves as a 15% decrease of the infarction zone-risk area ratio, a fewer number of arrhythmias and improvement of tissue perfusion during CPB. Intraoperative myocardial protection by nitric oxide in patients operated with CPB should be the object of further clinical research.</p><p>Received 19 June 2017. Revised 9 October 2017. Accepted 15 October 2017.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions:</strong> All the authors comply with 4 ICMJE authorship criteria and contributed equally at every stage of the study.</p><p><strong>Acknowledgement:</strong> The authors express their gratitude to Ekaterina S. Tokareva and Aleksandra A. Nenakhova for support in preparation of the article.</p>
topic защита миокарда
прекондиционирование
ишемически-реперфузионное повреждение
оксид азота
url https://journalmeshalkin.ru/index.php/heartjournal/article/view/468
work_keys_str_mv AT nokamenshchikov myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT iamandel myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT yukpodoksenov myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT slmikheev myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT sssementsov myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT lnmaslov myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT bnkozlov myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
AT vmshipulin myocardiumprotectionagainstischemicreperfusioninjurybynitricoxidesuppliedtotheextracorporealcirculationlineduringcardiopulmonarybypassexperimentalstudy
_version_ 1724409468567945216
spelling doaj-2d4561a0dbe84eb38e5006041897ef752020-12-02T04:15:03Zrus Meshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192017-12-01214798610.21688/1681-3472-2017-4-79-861141Myocardium protection against ischemic-reperfusion injury by nitric oxide supplied to the extracorporeal circulation line during cardiopulmonary bypass (experimental study)N. O. Kamenshchikov0I. A. Mandel1Yu. K. Podoksenov2S. L. Mikheev3S. S. Sementsov4L. N. Maslov5B. N. Kozlov6V. M. Shipulin7ФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская ФедерацияФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова, Министерство здравоохранения Российской Федерации (Сеченовский Университет), Москва, Российская Федерация; ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства», Москва, Российская ФедерацияФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская Федерация; ФГБОУ ВО «Сибирский государственный медицинский университет», Министерство здравоохранения Российской Федерации, Томск, Российская ФедерацияФГАУ «Лечебно-реабилитационный центр», Министерство здравоохранения Российской Федерации, Москва, Российская ФедерацияФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская ФедерацияФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская ФедерацияФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская Федерация; ФГБОУ ВО «Сибирский государственный медицинский университет», Министерство здравоохранения Российской Федерации, Томск, Российская ФедерацияФГБНУ «Томский национальный исследовательский медицинский центр Российской академии наук» «Научно-исследовательский институт кардиологии», Томск, Российская Федерация; ФГБОУ ВО «Сибирский государственный медицинский университет», Министерство здравоохранения Российской Федерации, Томск, Российская Федерация<p><strong>Aim.</strong> The study was designed to assess the efficiency of exogenous nitric oxide supply to the extracorporeal circulation line for myocardial protection against ischemic-reperfusion injury in acute myocardial infarction simulation during cardiopulmonary bypass (CPB) in the experiment. <br /><strong>Methods.</strong> Acute ischemia was simulated in rabbits (n = 20) with subsequent myocardial reperfusion. All animals were anesthetized and mechanically ventilated through a nasotracheal tube. The experiment included occlusion of the left coronary artery by its clamping with a ligature for 45 min with subsequent reperfusion for 120 min during CPB. All animals were divided into 2 equal groups: 10 rabbits received nitric oxide supply to the extracorporeal circulation line in a dose of 40 ppm throughout the entire CPB period (the main group); 10 rabbits made up the control group. The ratio of the infarction area to the risk area was determined, and the quantity and nature of ventricular arrhythmias were accessed. <br /><strong>Results.</strong> It was established that nitric oxide supply through the extracorporeal circulation line during CPB had a pronounced infarct-limiting effect, the infarct area to the risk area ratio decreased by 15% as compared to the control group, р = 0.0002. There was also a significant antiarrhythmic effect. A lesser quantity of polytopic and polymorphic ventricular extrasystoles were observed in the main group during periods of ischemia and reperfusion (p = 0.003 and p = 0.012). A statistically significant decrease in the venoarterial gradient of the partial pressure of carbon dioxide in the main group was associated with an increase in the urine flow rate amounting to 1.4 [1.3; 1.5] ml/kg/h in the main group and 1.15 [1; 1.3] ml/kg/h in the control group, p = 0.013. <br /><strong>Conclusion.</strong> The data obtained during the experiment demonstrate the presence of cardioprotective properties of nitric oxide delivered to the extracorporeal circulation line when simulating myocardial ischemic-reperfusion injury. These properties manifest themselves as a 15% decrease of the infarction zone-risk area ratio, a fewer number of arrhythmias and improvement of tissue perfusion during CPB. Intraoperative myocardial protection by nitric oxide in patients operated with CPB should be the object of further clinical research.</p><p>Received 19 June 2017. Revised 9 October 2017. Accepted 15 October 2017.</p><p><strong>Funding:</strong> The study did not have sponsorship.</p><p><strong>Conflict of interest:</strong> Authors declare no conflict of interest.</p><p><strong>Author contributions:</strong> All the authors comply with 4 ICMJE authorship criteria and contributed equally at every stage of the study.</p><p><strong>Acknowledgement:</strong> The authors express their gratitude to Ekaterina S. Tokareva and Aleksandra A. Nenakhova for support in preparation of the article.</p>https://journalmeshalkin.ru/index.php/heartjournal/article/view/468защита миокардапрекондиционированиеишемически-реперфузионное повреждениеоксид азота